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Biosynthesis of H2S is impaired in non-obese
diabetic (NOD) mice
V Brancaleone, F Roviezzo, V Vellecco, L De Gruttola, M Bucci and G Cirino
Department of Experimental Pharmacology, University of Naples, Naples, Italy
Background and purpose: Hydrogen sulphide (H2S) has been involved in cardiovascular homoeostasis but data about its role
in animal models of diabetic pathology are still lacking. Here, we have analysed H2S signalling in a genetic model of diabetes,
the non-obese diabetic (NOD) mice.
Experimental approach: NOD mice exhibit a progressive endothelial dysfunction characterized by a reduced reactivity of
blood vessels as diabetes develops. NOD mice were divided into three groups according to different glycosuria values: NOD I,
NOD II and NOD III. Age-matched non-obese resistant (NOR) mice were used as controls. H2S levels in plasma and aortic tissue
were measured. Functional studies in aorta were carried out in isolated organ baths using both an exogenous source of H2S
(NaHS) and the metabolic precursor (L-cysteine). Real time PCR and western blot analysis were also carried out on aortic
tissues.
Key results: NOD mice exhibited a progressive reduction of H2S plasma levels, which paralleled disease severity. L-cysteine-
induced H2S production by aortic tissues was also progressively reduced. L-cysteine-induced vasorelaxation was significantly
reduced in NOD mice while NaHS-induced relaxation was unaffected. ODQ (guanylate cyclase inhibitor), L-NAME (NO
synthase inhibitor) or PAG, an inhibitor of cystathionine-g-lyase (CSE) inhibited H2S production induced by L-cysteine.
Conclusions and implications: In NOD mice, endogenous H2S production is significantly impaired. Also, the ability of isolated
aorta to respond to exogenous H2S is enhanced and endothelium-derived NO appears to be involved in the enzymatic
conversion of L-cysteine into H2S.
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Introduction
Hydrogen sulphide (H2S) is a gas endogenously generated
from L-cysteine, a sulphur-containing amino acid derived
from alimentary sources or liberated from endogenous
proteins. L-cysteine can also be synthesized from L-methio-
nine through the transsulphuration pathway, with homo-
cysteine as an intermediate (Zhao et al., 2001; Chen et al.,
2004; Stipanuk, 2004). Production of H2S from L-cysteine is
catalysed by two enzymes: cystathionine-b-synthase (CBS)
and cystathionine-g-lyase (CSE). Both enzymes are pyridoxal-
50-phosphate (vitamin B6)-dependent but differ in the
specific mechanism of H2S formation (Braunstein and
Azarkh, 1950). CBS and CSE are widely distributed in
mammalian tissues and present data suggest that CBS is
predominantly expressed in the CNS, whereas CSE is mostly
present in the cardiovascular environment (Hosoki et al.,
1997; van der Molen et al., 1997; Levonen et al., 2000; Yap
et al., 2000; Meier et al., 2001; Wang, 2002; Moore et al.,
2003). However, presence of CBS has also been assessed in
endothelial cells (Wang et al., 1992).
Recent literature has supported the involvement of H2S in
cardiovascular homoeostasis (Zhong et al., 2003; Yan et al.,
2004; Bhatia, 2005; O’Sullivan, 2006; Pearson et al., 2006; Qu
et al., 2006). In particular, it has been demonstrated that H2S
(i) exhibits vasodilator activity in vitro and in vivo (Ali et al.,
2006), (ii) is pro-apoptotic on vascular smooth muscle cells
(Zhao et al., 2001; Cheng et al., 2004; Yang et al., 2004) and
(iii) is involved in leukocyte–endotheliium interactions
(Zanardo et al., 2006). All these findings, taken together with
the fact that H2S levels, as well as aortic CSE mRNA, are
reduced in spontaneously hypertensive rats, further support a
role for H2S in cardiovascular inflammation (Du et al., 2003).
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Here we have evaluated the effect of H2S on vascular tone
in a genetic model of diabetes in mice, the non-obese
diabetic (NOD) strain. NOD mice spontaneously develop
diabetes, where the autoimmune disease is directly asso-
ciated with a progressive endothelial dysfunction (Makino
et al., 1980; Bucci et al., 2004).
In particular, we have evaluated the effect of H2S on aortic
rings by using an exogenous source such as sodium
hydrosulphide hydrate (NaHS) or its physiological precursor
such as L-cysteine; this approach led us to evaluate both the
direct effect of H2S on vessels and the contribution of
endogenous pathways in regulating vascular tone.
Our results suggest that diabetes-related endothelial
dysfunction in NOD mice is associated with an impairment
of endogenous H2S production, without affecting the ability
of vascular tissue to react to exogenous sources of H2S.
Materials and methods
Animals
All animal procedures were in compliance with the European
Community guidelines for the use of experimental animals
and approved by the Committee Centro Servizi Veterinari of
the University Federico II; this work was carried out with
NOD/Ltj mice purchased from Charles River Laboratories
(Milan, Italy). All experiments were performed by using 7- to
27-week-old female mice. NOR/Ltj female mice were used as
age-matched controls. Animals were bred and housed in our
animal facility having free access to water and food.
NOD/Ltj mice
NOD mice represent a strain with an elevated susceptibility
in developing type 1 diabetes (IDDM) (Makino et al., 1980).
These mice show changes with evolution of pathology, in
particular there is an early phase characterized by a
localization of inflammatory cells, such as T cells and
activated macrophages, around pancreatic islet, inducing
peri-insulitis (4–10 weeks of age); consequently, these cells
infiltrate islets and initiate a progressive destruction of
pancreatic b cells, resulting in a drastic reduction in insulin
plasma levels (12–30 weeks of age). The progression of
diabetic pathology and its clinical outcomes in these animals
are similar to those in humans and associated with vascular
disorders. Indeed a gradual reduction of ACh-induced
relaxation was found in aortic tissues harvested from NOD
mice (Figure 1a) and this hyporeactivity correlated with a
reduced availability of circulating nitric oxide (NO) (Bucci
et al., 2004).
NOD mice were divided into three groups, as follows, by
measurement of glycosuria, and each group can be con-
sidered representative of different diabetic states (10 animals
per group). Indeed, NOD I is a mouse group in which
diabetic state is not yet present; NOD II group has glycosuria
and elevated glycaemia; NOD III group displays a severe
pathology with even higher levels of glycosuria and
glycaemia (Doi et al., 1990) (Figures 1b and c).
Glycosuria measurement
In these animals, diabetic state was assessed by using a non-
invasive approach such as measurement of glycosuria, the
increase of which is positively correlated to glycaemia.
Animals were deprived of food for 2 h to normalize glucose
plasma levels and then put in metabolic cages for 4 h, where
urine samples were collected. Glycosuria levels were mea-
sured by glucose-6-oxidase colorimetric assay (Trinder reac-
tion kit; Biogamma, Roma, Italy). According to the glucose
assays, mice were divided into three groups: NOD I,
glycosuria, 0–0.20 mg mL1; NOD II glycosuria, 0.2–
5 mg mL1; NOD III, glycosuria, 45 mg mL1 (Figure 1b), to
provide different stages of pathology.
Measurement of H2S: plasma and tissues
Tissue H2S production rate was measured according to
Stipanuk and Beck (1982), with modifications. Briefly, aortas
were homogenized in a lysis buffer (potassium phosphate
buffer 100 mM pH¼7.4, sodium orthovanadate 10 mM and
proteases inhibitors). Protein concentration was determined
by using Bradford assay (Bio-Rad Laboratories, Milano, Italy).
Homogenates were added to a reaction mixture (total
volume 500 mL) containing pyridoxal-50-phosphate (2 mM,
20 mL), L-cysteine (10 mM, 20 mL) and saline (30 mL). The
reaction was performed in sealed Eppendorf tubes and
initiated by transferring tubes from ice to a water bath at
37 1C. After 40 min incubation, zinc acetate (1%, 250 mL) was
added followed by trichloroacetic acid (10%, 250 mL). Subse-
quently, N,N-dimethylphenylendiamine sulphate (20 mM,
133 mL) in 7.2 M HCl and FeCl3 (30 mM, 133 mL) in 1.2 M
HCl were added and optical absorbance of the solutions was
measured after 20 min at a wavelength of 650 nm. All
samples were assayed in duplicate and H2S concentration
was calculated against a calibration curve of NaHS (3.12–
250 mM). To determine basal release of H2S, L-cysteine was not
added to the reaction mixture. Results were expressed as
nmol per milligram of protein per minute (nmol per mg
protein per min).
Plasma determination of H2S was performed without
addition of L-cysteine. Plasma samples (100 mL) were added
to Eppendorf tubes containing zinc acetate (1 % 150 mL).
Trichloroacetic acid (10 % 300 mL) was then added. Subse-
quently, N,N-dimethylphenylendiamine sulphate (20 mM,
100 mL) in 7.2 M HCl and FeCl3 (30 mM, 133 mL) in 1.2 M
HCl were added to the reaction mixture and absorbance of
the solution was measured after 20 min at a wavelength of
650 nm. All samples were assayed in duplicate and H2S
concentration was calculated against a calibration curve of
NaHS (3.12–250 mM).
Tissue preparation
Animals were killed at different stages of pathology with
age-matched NOR mice control and aortas were excised and
plasma collected from each animal. Then tissues and plasma
were used to quantify H2S amount by using the method
described above. Furthermore, aortic tissues were also used
for functional studies in isolated organ baths filled with
oxygenated Krebs solution at 37 1C, linked to isometric force
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transducers (Fort 10, Ugo Basile, Comerio, Varese, Italy). The
composition of Krebs solution was as follows (in mM): NaCl
118, KCl 4.7, MgSO4 1.2, KH2PO4 1.2, CaCl2 2.5, NaHCO3 25
and glucose 11. Rings were stretched until a resting tension of
1.5 g was reached and allowed to equilibrate for at least 45 min
during which time tension was adjusted, as necessary, to 1.5 g
and bathing solution was periodically changed. In a pre-
liminary study, a resting tension of 1.5 g was found to develop
optimal tension to stimulation with contracting agents.
In another set of experiments, aortic tissues harvested from
NOR mice were incubated with 1H-[1,2,4]oxadiazolo[4,3-
a]quinoxalin-1-one (ODQ) (5mM), No-nitro-L-arginine methyl
ester (L-NAME) (100mM) and DL-propargylglycine (PAG)
(10 mM) for 15 min at 37 1C in six-well plates in an oxygenated
environment and then challenged with L-cysteine (3 mM) for
5 min. After incubation, tissues were snap-frozen in liquid
nitrogen and H2S content was determined.
Experimental protocol and drug treatments
In our experiments, we used 5-HT as vasoconstrictor agent, as
its action is unaffected in NOD mice (Bucci et al., 2004). In
each set of experiments, rings were first challenged with 5-HT
(1mM) until the responses were reproducible. To verify
endothelium integrity, an ACh cumulative concentration–
response curve (10nM–30mM) was performed on 5-HT-precon-
tracted rings. In this study, we used both NaHS and L-cysteine
as source of H2S, a direct H2S donor and the physiological
metabolic precursor, respectively. In particular, H2S release
from L-cysteine is correlated to enzymatic activity of both CBS
and CSE. NaHS and L-cysteine cumulative concentration–
response curves were performed on 5-HT-precontracted rings
harvested from NOR and NOD I, II and III mice.
A preliminary study on the optimal incubation time of the
drug treatments and concentration was carried out (data not
shown). L-NAME (100 mM) and ODQ (5mM) were added to the
organ baths containing 5-HT-precontracted rings. After
15 min of incubation, cumulative concentration–response
curves to NaHS and L-cysteine were performed.
Western blots
Aortic tissue or BAEC was homogenized in modified RIPA
buffer (Tris-HCl 50 mM, pH 7.4, Triton 1%, Na-deoxycholate
0.25%, NaCl 150 mM, EDTA 1 mM, phenylmethanesulpho-
nylfluoride 1 mM, aprotinin 10 mg mL1, leupeptin 20 mM,
NaF 50 mM) using a Polytron homogenizer (two cycles of 10 s
at maximum speed). After centrifugation of homogenates at
6500 g for 10 min, 10, 30 mg of the denatured proteins were
separated on 10% sodium dodecyl sulphate polyacrylamide
gels and transferred to a polyvinylidene fluoride membrane.
Membranes were blocked by incubation in phosphate-
buffered saline containing 0.1% v/v Tween 20 and 5% non-
fat dry milk for 2 h, followed by overnight incubation at 4 1C
with mouse polyclonal CBS (Abnova Novus Biologicals,
Littleton, CO, USA) antibody (1:500) or mouse monoclonal
CSE (Abnova Novus Biologicals) antibody (1:500). The filters
were washed extensively in phosphate-buffered saline con-
taining 0.1% v/v Tween 20, before incubation for 2 h with
anti-horseradish-peroxidase-conjugated secondary antibody.
Membranes were then washed and developed using En-
hanced Chemiluminescence Substrate (ECL; Amersham
Pharmacia Biotech, San Diego, CA, USA).
Quantitative real-time PCR
Quantization of the expression level of selected genes was
performed by quantitative real-time PCR. Total RNA was
isolated with TRIzol reagent (Invitrogen, Carlsbad, CA, USA)
from mouse aortic rings. One microgram RNA was incubated
with DNaseI (Invitrogen) for 15 min at room temperature
followed by 95 1C for 5 min in the presence of 2.5 mM EDTA.
The RNA was reverse-transcribed with Superscript III (Invi-
trogen) with random primers in a volume of 20 mL. For real-
time PCR, 10 ng template was used in a 25 mL reaction
containing 0.3 mM each primer and 12.5 mL of 2 DyNAmo
SYBR Green qPCR Kits (Finnzymes, Espoo, Finland).
All reactions were performed in triplicate using the
following cycling conditions: 10 min at 95 1C, followed by
50 cycles of 95 1C for 10 s, 60 1C for 20 s and 72 1C for 20 s,
using an iCycler iQ instrument (Biorad, Hercules, CA, USA).
The mean value of the replicates for each sample was
calculated and expressed as cycle threshold (CT: cycle
number at which each PCR reaches a predetermined
fluorescence threshold, set within the linear range of all
reactions). The amount of gene expression was then
calculated as the difference (DCT) between the CT value of
the sample for the target gene and the mean CT value of that
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Figure 1 (a) ACh-induced vasorelaxation was progressively reduced in NOD mice (**Po0.01 vs NOD I; ***Po0.001 vs NOD I;
two-way ANOVA). (b) Glycosuria was progressively increased in NOD mice. (c) Increase in blood glucose levels was related to glycosuria
(glycosuria: NOD I: 0 mg mL1; NOD II: B0.8 mg mL1; NOD III: B8 mg mL1; blood glucose: NOD I: B0.9 mg mL1; NOD II:
B2.5 mg mL1; NOD III: B5 mg mL1) (**Po0.01 vs NOD I; ***Po0.001 vs NOD I; ##Po0.01 vs NOD II; one-way ANOVA). Discontinuous
line indicates physiological value of blood glucose. NOD, non-obese diabetic.
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sample for the endogenous control (GAPDH). Relative
expression was calculated as the difference (DDCT) between
the DCT values of the test and control samples for each target
gene. The relative level of expression was measured as
2DDCT . All PCR primers were designed using the software
PRIMER3-OUTPUT using published sequence data obtained
from the NCBI database.
Mouse primers were as follows: CBS, (FWD)
agaagtgccctggctgtaaa and (REV) caggactgtcgggatgaagt; CSE,
(FWD) tgctgccaccattacgatta and (REV) gatgccaccctcctgaagta;
GAPDH, (FWD) ctgagtatgtcgtggagtctac and (REV)
gttggtggtgcaggatgcattg.
Statistical analysis
All data were expressed as mean±s.e.mean. Statistical
analysis was performed by using one-way ANOVA and
Dunnet as post-test, or two-way ANOVA and Bonferroni as
post-test. Differences were considered statistically significant
when P-value was less than 0.05.
Drugs
ACh, 5-HT, L-NAME, ODQ, pyridoxal-50-phosphate hydrate,
iron chloride (III) (FeCl3), N,N-dimethylphenylendiamine
sulphate, zinc acetate and PAG were purchased from Sigma
Chemical Co. (Milano, Italy). Trichloroacetic acid was
purchased from Carlo Erba Reagents (Milano, Italy). NaHS
and L-cysteine hydrochloride were purchased from Aldrich
(Milano, Italy). Kit for enzymatic measurement of glucose
levels (Trinder reaction kit) was purchased from BioGamma.
Results
Impairment of H2S production in NOD mice
Plasma concentrations of H2S were between 50 and 65 mM in
NOR mice. NOD mice exhibited a progressive reduction in
H2S plasma levels, which paralleled the pathology develop-
ment; in particular in NOD III mice, where the pathology is
well established, there was a 50% reduction in H2S levels
(Figure 2a; **Po0.01 vs NOR; n¼6).
To assess if impaired H2S production was reflected by an
analogous dysfunction at vascular level, we evaluated the
production of H2S in aortic tissues harvested from NOR or
NOD mice. Our results showed that H2S basal production
was not affected in NOD mice (data not shown), whereas the
ability to convert L-cysteine into H2S was significantly
impaired in aortic tissues harvested from NOD II mice and
even more so in NOD III mice (Figure 2b; *Po0.05; **Po0.01
vs NOR; n¼6).
Disease progression significantly affects L-cysteine-induced
relaxation in NOD mice
NaHS (1mM–3 mM) induced a concentration-dependent
vasorelaxation on 5-HT precontracted aortic rings harvested
from NOR mice that was not affected by L-NAME (100 mM)
pretreatment (Figure 3a). The relaxant response induced by
NaHS in aortic rings from NOD I and NOD II mice was not
significantly different from NOR mice (Figure 3c). Conver-
sely, in NOD III mice, in which the pathology is well
established and the endothelium is severely damaged, NaHS-
induced vasorelaxation was significantly increased
(Figure 3c; Po0.01 vs NOR; n¼6).
Administration of L-cysteine (1 mM–3 mM) induced a
relaxant effect on NOR mice aortic tissues, which was
significantly inhibited by L-NAME (Figure 3b; ***Po0.001
vs vehicle; n¼6). Disease progression leads to a significant
decrease in L-cysteine-induced vasodilatation of aortic rings
harvested from NOD II or NOD III mice (Figure 3d; **Po0.01
and ***Po0.001 vs NOR respectively; n¼6). Endothelial
removal did not affect vasorelaxation induced by either
NaHS or L-cysteine (data not shown).
NO/cGMP signalling is involved in L-cysteine-induced
vasorelaxation
As we found that L-cysteine elicited an L-NAME-sensitive
vasorelaxation and that its vasorelaxant effect was signi-
ficantly reduced in NOD mice, we investigated the
involvement of NO/cGMP pathway in the relaxant effects
of L-cysteine by using ODQ, an NO-sensitive GC inhibitor.
Incubation of NOR aortic rings with ODQ (5 mM, 10 min,
n¼6) inhibited L-cysteine-induced relaxation (Figure 4a;
***Po0.001 vs vehicle; n¼6).
A similar pattern of inhibition was obtained in NOD mice
aortas. In particular, in NOD III mice, the already impaired
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Figure 2 (a) Plasma levels of H2S gradually decrease in NOD mice
(**Po0.01 vs NOR; one-way ANOVA). (b) L-cysteine-stimulated H2S
production in aortic tissues was significantly reduced in NOD II or NOD
III mice (*Po0.05 and **Po0.01 vs NOR; one-way ANOVA). Basal
values were unchanged (data not shown). NOD, non-obese diabetic.
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Figure 3 (a) NaHS vasorelaxant effect was not modified by L-NAME (100mM) in NOR mice. (b) L-NAME (100mM) pretreatment affected
L-cysteine vasorelaxation in NOR mice (***Po0.001 vs vehicle; two-way ANOVA). (c) NaHS-induced vasorelaxation was not significantly
affected in NOD I or NOD II mice, but enhanced in NOD III mice (dashed line: NOR mice) (Po0.01 vs NOR). (d) L-cysteine-induced
vasodilatation was impaired in NOD mice and paralleled the disease development (dashed lines: NOR mice) (**Po0.01 vs NOR; ***Po0.001 vs
NOR; two-way ANOVA). L-NAME, No-nitro-L-arginine methyl ester; NOD, non-obese diabetic.
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Figure 4 ODQ (5mM) does not affect NaHS-induced vasorelaxation either in (a) NOR or in (c) NOD III mice (ns, n¼5). Conversely, in (b),
ODQ (5mM) significantly inhibits L-cysteine-induced vasorelaxant response in NOR mice (***Po0.001 vs vehicle, n¼5; two-way ANOVA). (d)
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ANOVA). NOD, non-obese diabetic; ODQ, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.
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L-cysteine-induced vasorelaxation was abolished by pretreat-
ment with ODQ (Figure 4d; ***Po0.001 vs vehicle; n¼6).
Conversely, the GC inhibitor did not affect NaHS-induced
vasorelaxation in either NOR or NOD III mice (Figures 4a
and c).
ODQ and L-NAME affect L-cysteine-derived H2S production
The inhibitory effect of ODQ on L-cysteine-induced vaso-
relaxation suggested an involvement of the NO/cGMP
pathway in H2S signalling; to assess if this inhibitory effect
was ascribed to the ability of ODQ to interfere with H2S
release, aortic tissues harvested from NOR mice were
incubated with L-cysteine in the presence of ODQ (5 mM,
15 min, n¼3), and H2S production was measured; in another
set of experiments, aortic tissues were pretreated with
L-NAME or the CSE inhibitor, PAG (10 mM, 15 min).
Data obtained showed that incubation with ODQ or
L-NAME reduced L-cysteine-induced H2S release in aortic
tissues, as well as that with PAG (Figure 5; *Po0.05 vs
L-cysteine), whereas they did not affect H2S basal release
(data not shown).
CBS and CSE expression is increased in NOD mice
Western blot and real-time PCR analysis was performed to
evaluate if low levels of H2S in NOD mice correlated with a
reduced expression of CBS or CSE. Despite the reduced
circulating and tissue H2S levels measured in NOD mice,
both western blot (Figure 6a) and quantitative real-time PCR
(Figure 6b) showed a significant upregulation of either CBS
and CSE in vessels harvested from NOD II and NOD III mice.
This finding could be ascribed to a compensatory response to
restore physiological H2S production.
Discussion
NOD mice gradually develop a type 1 diabetes (Makino et al.,
1980) that is characterized by a progressive endothelial
dysfunction leading to an impaired response of vascular
tissues in vitro (Bucci et al., 2004). Here we have addressed the
involvement of the H2S pathway in vascular dysfunction in
NOD mice. When we measured H2S plasma levels, we found
values around 50 mM in NOR mice, whereas NOD mice
exhibited a progressive reduction of H2S plasma levels that
paralleled the disease severity, reaching 50% reduction in
NOD III mice. To determine if the reduced plasma levels
reflected a similar impairment in the vessels, we determined
the amount of H2S produced by homogenates of aortic
tissues harvested from NOR, NOD I, NOD II or NOD III mice;
the assay was performed both in the absence (basal) and in
the presence (stimulated) of the substrate L-cysteine.
Although the basal release of H2S was unchanged, the
stimulated production was progressively reduced, paralleling
the disease progression.
Taken together, the biochemical data suggest that in this
experimental model, there is a gradual impairment of
H2S production. The functional studies showed that in
NOD mice, the response to exogenous H2S (as NaHS) was
not altered whereas the response to L-cysteine was impaired.
Indeed, responses of NOD mice to NaHS were not signifi-
cantly different from those of NOR (background) mice, with
the only exception of NOD III mice where they were
potentiated. Conversely, L-cysteine-induced vasodilatation
was significantly impaired in all three NOD groups, parallel-
ing the disease progression. As NOD mice exhibited a specific
impairment in NO-mediated vasorelaxation (Bucci et al.,
2004), we assessed the involvement of the endothelium-
derived NO in L-cysteine-induced vasorelaxation. Functional
studies showed that in physiological conditions (NOR mice),
L-NAME pretreatment significantly reduced L-cysteine-
induced vasorelaxation, whereas NaHS-induced vasodilata-
tion was unaffected. A similar pattern was observed in NOD I
mice that have normal glycosuria/glycaemia. Thus, the
endothelial-derived NO pathway seems to be involved in
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Figure 5 (a) Addition of exogenous L-cysteine (3mM) to aortic
tissues increased production of H2S by 40% (139±10 nmol per mg
tissue), an effect that is lost when aortic tissues were pretreated with
ODQ (5mM) or L-NAME (100mM). PAG (10 mM), an inhibitor of CSE,
was used as positive control (*Po0.05 vs L-cysteine; one-way ANOVA,
n¼3). In (b), the data from (a) are expressed as % inhibition of
L-cysteine-derived H2S production. The inhibitors used were without
effect on basal H2S release (data not shown). CSE, cystathionine-
g-lyase; L-NAME, No-nitro-L-arginine methyl ester; ODQ, 1H-[1,2,4]
oxadiazolo[4,3-a]quinoxalin-1-one; PAG, DL-propargylglycine.
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L-cysteine-induced vasorelaxation, as also confirmed by
experiments performed with ODQ.
It has been shown that H2S-induced vasorelaxation is not
affected by endothelium removal, suggesting that endothe-
lium is not involved in the H2S effect at vascular level
(Hosoki et al., 1997; Zhao et al., 2001; Wang, 2002). This
finding is apparently in contrast with our data. However, it
has to be said that mechanical removal of endothelium only
partially mimics the pathological condition known as
endothelial dysfunction. Indeed, the alteration of endo-
thelium functionality, in the majority of the cases, is a
gradual and progressive process and cannot be simply and
directly related to a mechanical and a nonspecific disruption
of whole endothelium. Therefore, it is feasible that modula-
tion of GC, in turn, could modulate L-cysteine-induced
response (endogenous H2S response; that is, involving
conversion of the substrate) without affecting NaHS-induced
vasodilatation (exogenous H2S response). To test this
hypothesis, we compared the vasodilatory response elicited
by either NaHS or L-cysteine following pharmacological
modulation with ODQ, an inhibitor of soluble GC. This
comparison was performed by using tissues harvested from
either NOR (normal) or NOD III mice (severe diabetes). As
expected, incubation with ODQ did not affect NaHS-induced
vasorelaxation in either NOR or NOD III mice, whereas it did
cause a marked inhibition of L-cysteine-induced vasorelaxa-
tion. In particular, L-cysteine-induced vasorelaxation was
significantly inhibited in rings harvested from NOR mice
and abolished in tissues harvested from NOD III mice, where
the L-cysteine response was already impaired. These findings,
together with the previous data, imply that, in NOD mice,
endogenous L-cysteine-induced vasorelaxation (endogenous
H2S) could be modulated by the NO pathway through GC
activation.
Different levels of interaction have been shown for NO
and H2S pathways. Thus, NO may directly act on CSE protein
to increase its activity (Zhao et al., 2003). Also, NO may
increase the activity of cGMP-dependent protein kinase,
which in turn stimulates CSE, and NO can upregulate the
expression of CSE, promoting cell uptake of cysteine, the
substrate for CSE (Zhang and Hogg, 2005; Sheng and
Wharton, 2006).
To assess if both L-NAME and ODQ inhibited L-cysteine-
induced vasorelaxation by reducing L-cysteine-derived H2S
production, we measured H2S in aortic tissues harvested
from NOR mice. Our results showed that ODQ,
L-NAME or the CSE inhibitor PAG, significantly affected
the ability of vascular tissue to metabolize L-cysteine in H2S.
In conclusion, our results showed that endogenous H2S
production is significantly impaired in hyperglycaemic
conditions in NOD mice, although the ability of vascular
tissue to respond to exogenous H2S was not altered.
Furthermore, we suggest that endothelium-derived NO has
an active role in modulating activity of the L-cysteine/H2S
NOR I II III
NO
R
NO
D I
NO
D I
I
NO
D I
II
NO
R
NO
D I
NO
D I
I
NO
D I
II
0
5
10
15
CSE
200
400
600
800 CBS
m
R
N
A
 2
-d
dC
t
** **
***
***
# #
###
###
NOR       I    II III
NOD
β-actin
CBS CSE
0.0
0.5
1.0
1.5
2.0
**##
##
*
*
R
el
at
iv
e 
O
.D
. (a
rb
itr
ar
y u
nit
s)
0.00
0.25
0.50
0.75
1.00
1.25
*
**
##
##
*
R
el
at
iv
e 
O
.D
. (a
rb
itr
ar
y u
nit
s)
β-actin
NOD
Figure 6 (a) Western blots show a significant increase in both CBS and CSE expression in NOD mice (*Po0.05 vs NOR; **Po0.01 vs NOR;
##Po0.01 vs NOD I; one-way ANOVA). Similarly, in (b), qRT-PCR confirmed the progressively increased expression of mRNA for CBS and CSE
(**Po0.01 vs NOR; ***Po0.001 vs NOR; #Po0.05 vs NOD I; ###Po0.001 vs NOD I; one-way ANOVA). CBS, cystathionine-b-synthase; CSE,
cystathionine-g-lyase; NOD, non-obese diabetic; qRT-PCR, quantitative real-time PCR.
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pathway and that the reduced vasorelaxant effect of
L-cysteine may originate in a reduced ability of vascular
tissue to convert L-cysteine to H2S.
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